Biotricity, Inc. (NASDAQ:BTCY) Sees Large Increase in Short Interest

Biotricity, Inc. (NASDAQ:BTCY) was the recipient of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 205,000 shares, a growth of 131.6% from the February 29th total of 88,500 shares. Based on an average trading volume of 70,600 shares, the short-interest ratio is presently 2.9 days. Currently, 2.6% of the company’s shares are sold short.

Biotricity Price Performance

Shares of BTCY stock traded up $0.12 on Thursday, hitting $1.48. The stock had a trading volume of 25,782 shares, compared to its average volume of 72,737. The company has a fifty day moving average price of $1.07 and a two-hundred day moving average price of $1.30. Biotricity has a twelve month low of $0.70 and a twelve month high of $5.10.

Biotricity (NASDAQ:BTCY) last released its quarterly earnings data on Tuesday, February 20th. The company reported ($0.34) earnings per share for the quarter, topping the consensus estimate of ($0.41) by $0.07. The firm had revenue of $2.97 million for the quarter, compared to analyst estimates of $3.00 million. On average, equities research analysts forecast that Biotricity will post -1.55 earnings per share for the current year.

Biotricity Company Profile

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.